(Q50673052)

17 March 2018

title

Health related quality of life among persons with HIV after the use of protease inhibitors. (English)

1 reference

17 March 2018

1 reference

7

1 reference

17 March 2018

author name string

S Low-Beer

1

1 reference

17 March 2018

K Chan

2

1 reference

17 March 2018

E Wood

3

1 reference

17 March 2018

B Yip

4

1 reference

17 March 2018

J S Montaner

5

1 reference

17 March 2018

M V O'Shaughnessy

6

1 reference

17 March 2018

publication date

1 January 2000

1 reference

17 March 2018

published in

Quality of Life Research

1 reference

17 March 2018

volume

9

1 reference

17 March 2018

issue

8

1 reference

17 March 2018

page(s)

941-949

1 reference

17 March 2018

https://scigraph.springernature.com/pub.10.1023/a:1008985728271

exact match

0 references

cites work

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

12 December 2020

Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors

1 reference

12 December 2020

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

12 December 2020

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

1 reference

12 December 2020

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

12 December 2020

Quality of life as a function of HIV classification

1 reference

12 December 2020

British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee

1 reference

12 December 2020

Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group.

1 reference

12 December 2020

Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES).

1 reference

12 December 2020

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

Emerging international consensus for use of antiretroviral therapy

1 reference

12 December 2020

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group

1 reference

12 December 2020

Measuring health-related quality of life among patients infected with human immunodeficiency virus

1 reference

12 December 2020

Measuring quality of life in early HIV disease: the modular approach

1 reference

12 December 2020

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study

1 reference

12 December 2020

Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group

1 reference

12 December 2020

Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3.

1 reference

12 December 2020

1 reference

12 December 2020

Disease severity, physical limitations and depression in HIV-infected men.

1 reference

12 December 2020

Human immunodeficiency virus (HIV) in America, 1981 to 1997: epidemiologic and therapeutic considerations

1 reference

12 December 2020

Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008985728271

1 reference

17 March 2018

Dimensions Publication ID

1052689250

0 references

1 reference

17 March 2018